🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nicholas G. Cost

Children's Hospital Colorado

ORCID: 0000-0002-5785-3704

Also affiliated with University of Colorado Denver

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.241Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children’s Oncology Group Study, AREN03B2

Journal of the American College of Surgeons(2024)10.1097/xcs.0000000000000999
Top 61%
0.241DataRank
Top 61%4 citations

Lindsay A. Renfro, Daniel J. Benedetti, Meera Kotagal, Hannah M. Phelps, Peter F. Ehrlich +13 more

Papers

Driven by 12 papers — median percentile 39. Top paper: “Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children’s Oncology Group Study, AREN03B2”.

Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children’s Oncology Group Study, AREN03B2

Journal of the American College of Surgeons(2024)10.1097/xcs.0000000000000999
Top 61%
0.241DataRank
Top 61%4 citations

Lindsay A. Renfro, Daniel J. Benedetti, Meera Kotagal, Hannah M. Phelps, Peter F. Ehrlich +13 more

Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of DICER1 syndrome

Journal of Medical Genetics(2021)10.1136/jmedgenet-2020-107434
N/A
0DataRank · unranked
14 citations

Lauren M. Vasta, Valérie Duflos, Carole Corsini, Catherine Dubois d’Enghien, Mary L. McMaster +17 more

Sexual dimorphic impacts of systemic vincristine on lower urinary tract function

Scientific Reports(2022)10.1038/s41598-022-08585-3
N/A
0DataRank · unranked
7 citations

Sarah L. Hecht, Dexiang Gao, Duncan T. Wilcox, Anna P. Malykhina, Nicholas G. Cost +1 more

Children's Oncology Group's 2023 blueprint for research: Renal tumors

Pediatric Blood & Cancer(2023)10.1002/pbc.30586
N/A
0DataRank · unranked
29 citations

Andrew L. Hong, Kelly Vallance, Nick Evageliou, Jennifer H. Aldrink, Nicholas G. Cost +4 more

Children's Oncology Group's 2023 blueprint for research: Surgery

Pediatric Blood & Cancer(2023)10.1002/pbc.30766
N/A
0DataRank · unranked
8 citations

Timothy B. Lautz, Marcus M. Malek, Nicholas G. Cost, Erika A. Newman, Roshni Dasgupta +4 more

Long‐term outcomes and patterns of relapse in patients with bilateral Wilms tumor or bilaterally predisposed unilateral Wilms tumor, a report from the COG AREN0534 study

International Journal of Cancer(2024)10.1002/ijc.35080
N/A
0DataRank · unranked
10 citations

Jack Brzezinski, Lindsay A. Renfro, Brett Tornwall, Marcus M. Malek, Daniel J. Benedetti +15 more

Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534

Pediatric Blood & Cancer(2024)10.1002/pbc.30981
N/A
0DataRank · unranked
7 citations

Jennifer H. Aldrink, Lindsay A. Renfro, Elizabeth A. Mullen, Andrew J. Murphy, Jack Brzezinski +16 more

Lower urinary dysfunction as a long-term effect of childhood vincristine treatment, with potential influences by sex and dose

Scientific Reports(2024)10.1038/s41598-024-65313-9
N/A
0DataRank · unranked
3 citations

Ali Teimouri, Duncan T. Wilcox, Anna P. Malykhina, Nicholas G. Cost, Naoko Iguchi

Updated favourable-histology Wilms tumour risk stratification: rationale for future Children’s Oncology Group clinical trials

Nature Reviews Urology(2025)10.1038/s41585-025-01055-1
N/A
0DataRank · unranked
13 citations

Nicholas G. Cost, Peter F. Ehrlich, Nicholas F. Evageliou, Elizabeth Fialkowski, Lauren Parsons +13 more

Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor

Annals of Surgery(2025)10.1097/sla.0000000000006726
N/A
0DataRank · unranked
3 citations

Kelly Vallance, Ian Tfirn, Nicholas F. Evageliou, Daniel J. Benedetti, Robert C. Shamberger +15 more

A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study

Cancer(2020)10.1002/cncr.33173
N/A
0DataRank · unranked
26 citations

Nicholas G. Cost, Yueh‐Yun Chi, Brett Tornwall, Mariana M. Cajaiba, Elizabeth J. Perlman +9 more

AREN1721, a randomized phase 2 trial of axitinib+nivolumab combination therapy vs. single agent nivolumab for the treatment of TFE/translocation renal cell carcinoma (tRCC) across all age groups, an NCI National Clinical Trials Network (NCTN) phase 2 study.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.4521
N/A
0DataRank · unranked
7 citations

Lindsay A. Renfro, Matthew R. Zibelman, Ana M. Molina, Mamta Parikh, Luke Pater +8 more